Genes2Me unveils CDSCO approved CoviEasy self-test kit for COVID

The test device also comes with a unique QR code for unique patient data entry and accurate report generation.

Published On 2022-06-13 11:53 GMT   |   Update On 2022-06-13 11:53 GMT

New Delhi: Genes2Me Pvt. Ltd. has announced the launch of its CoviEasy Self-Test Rapid Antigen test kit for COVID-19 that gives results in 10 minutes.

"Backed by AI driven Mobile App, this IVD product delivers high level of sensitivity and concordance of more than 98% accuracy," the company said in its release.

CoviEasy has undergone stringent quality checks at ICMR approved Validation center and further received approval from CDSCO India. CoviEasy test can be easily performed by following simple instructions provided on the Mobile App (which is available on both Android and iOS platforms) leading to Automated Reporting of test results from this Mobile App itself.

The CoviEasy test involves couple of steps as is conducted with a nasal swab sampling, wherein the swab first need to be inserted in the nostrils. The swab needs to be dipped in the buffer tube and swirl 8-10 times in the extraction buffer. The Buffer is then dropped onto the CoviEeasy test device which shows test result as either positive or negative. The test device also comes with a unique QR code for unique patient data entry and accurate report generation.

Read also: ICMR approves Odisha made COVID rapid antigen test kit

Mr. Neeraj Gupta, the Founder and CEO of Genes2Me Pvt. Ltd. while commenting on the launch of product said, "Now that many of us are opting for "At-home" test kits as our first line of defense against COVID, "Accuracy" becomes non-negotiable/most Important factor. We understood the need of the hour and came up with a test kit which is more than 98% accurate. Our Covieasy kit will provide almost the assurances of RTPCR with the convenience of "at-home" self-test kit. We plan to help the society with India's most accurate kit and meet the requirement with our advanced manufacturing unit."

Read also: Cipla introduces 'RT-Direct' multiplex COVID-19 RT PCR Test kit in India

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News